Evaxion A/S

US$3.00As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EVAXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (56.64%)
Div yield —
ROE (109.86%)
Biotechnology
Beta (5Y) 0.56
PE TTM —
TSR TTM (47.83%)
Mkt cap US$25.02M
ROIC (31.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.64
21.44%
(76.34%)
Hold 10|7|8|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
19.66%
12.88%
3.56%
(1.64%)
Revenue$M
1.324
1.349
1.309
1.340
12.66%
13.05%
5.69%
4.33%
Peers (US$25.02M)
Cap (US$)
PE
50.25M
—
Capital
TTM
5Y
10Y
Leveragex
2.293
0.383
0.372
EBIT/Intx
1.591
0.076
0.075
Own earn%
53.83
(65.07)
(31.69)
Sh yield%
24.14
34.05
39.19
Owners
Insiders/Inst%
3.49
60.25
Short interest%
1.99
SBC / revenue%
4.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
15–20
$1 testx
0.0
Incr. ROIC%
5